VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Nuzyra

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 88 out of 100

NUZYRA may be the treatment option you’ve been looking for

Also known as Paratek Pharmaceuticals, Inc.

  • Biotech & therapeutics
Status
Operatingas of 2026-09-17
Legal name
Paratek Pharmaceuticals, Inc.
Claim, correct or request removal

Record updated 28 September 2026

About

Your doctor chose once-daily* NUZYRA to treat certain bacterial infections.

Funding snapshot

Total raised
$93MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round
Round, $93M2014-06-30

Funding rounds

Round, 2014
$93M2014-06-30, SEC form D sold, 54 investors

Products

Other
NUZYRA
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy